{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:12:21Z","timestamp":1789823541499,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10875-018-0578-8","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T08:57:08Z","timestamp":1544777828000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies"],"prefix":"10.1007","volume":"39","author":[{"given":"J\u00e9r\u00f4me","family":"Hadjadj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Guffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Delavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fresard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"L\u2019Honneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"D\u2019Aveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Rosain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lecuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"578_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CDS, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25:471\u2013506.","journal-title":"Clin Microbiol Rev"},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013;80:1430\u20138.","journal-title":"Neurology"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","volume":"140","author":"A Fischer","year":"2017","unstructured":"Fischer A, Provot J, Jais J-P, Alcais A, Mahlaoui N, Members of the CEREDIH French PID study group. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140:1388\u20131393.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"578_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96\u2013128.","journal-title":"J Clin Immunol"},{"key":"578_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2010.08.014","volume":"33","author":"R P\u00e9rez de Diego","year":"2010","unstructured":"P\u00e9rez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 2010;33:400\u201311.","journal-title":"Immunity"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/cid\/civ1220","volume":"62","author":"CS Zerbe","year":"2016","unstructured":"Zerbe CS, Marciano BE, Katial RK, Santos CB, Adamo N, Hsu AP, et al. Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;62:986\u201394.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"578_CR7","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1086\/318120","volume":"31","author":"S Haider","year":"2000","unstructured":"Haider S, Nafziger D, Gutierrez JA, Brar I, Mateo N, Fogle J. Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases. Clin Infect Dis Off Publ Infect Dis Soc Am. 2000;31:E20\u20132.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1086\/500400","volume":"42","author":"MA Rueger","year":"2006","unstructured":"Rueger MA, Miletic H, Dorries K, Wyen C, Eggers C, Deckert M, et al. Long-term remission in progressive multifocal leukoencephalopathy caused by idiopathic CD4+ T lymphocytopenia: a case report. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;42:e53\u20136.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"578_CR9","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/jac\/dkq389","volume":"65","author":"A Patel","year":"2010","unstructured":"Patel A, Patel J, Ikwuagwu J. Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother. 2010;65:2489\u201392.","journal-title":"J Antimicrob Chemother"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2016.08.002","volume":"178","author":"L Shekaili Al","year":"2017","unstructured":"Al Shekaili L, Sheikh F, Al Gazlan S, Al Dhekri H, Al Mousa H, Al Ghonaium A, et al. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. Clin Immunol Orlando Fla. 2017;178:39\u201344.","journal-title":"Clin Immunol Orlando Fla"},{"key":"578_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archneur.64.2.273","volume":"64","author":"Z Aschermann","year":"2007","unstructured":"Aschermann Z, Gomori E, Kovacs GG, Pal E, Simon G, Komoly S, et al. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol. 2007;64:273\u20136.","journal-title":"Arch Neurol"},{"key":"578_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","volume":"35","author":"F Dhalla","year":"2015","unstructured":"Dhalla F, Murray S, Sadler R, Chaigne-Delalande B, Sadaoka T, Soilleux E, et al. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J Clin Immunol. 2015;35:112\u20138.","journal-title":"J Clin Immunol"},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2016.12.013","volume":"179","author":"C Schr\u00f6der","year":"2017","unstructured":"Schr\u00f6der C, Baerlecken NT, Pannicke U, D\u00f6rk T, Witte T, Jacobs R, et al. Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy. Clin Immunol Orlando Fla. 2017;179:1\u20137.","journal-title":"Clin Immunol Orlando Fla"},{"key":"578_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova J-L, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.","journal-title":"Front Immunol"},{"key":"578_CR15","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1172\/JCI25178","volume":"115","author":"J-P Villartay de","year":"2005","unstructured":"de Villartay J-P, Lim A, Al-Mousa H, Dupont S, D\u00e9chanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291\u20139.","journal-title":"J Clin Invest"},{"key":"578_CR16","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1182\/blood.V88.5.1708.1708","volume":"88","author":"E Morelon","year":"1996","unstructured":"Morelon E, Dautry-Varsat A, Le Deist F, Hacein-Bay S, Fischer A, de Saint Basile G. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient. Blood. 1996;88:1708\u201317.","journal-title":"Blood"},{"key":"578_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ene.12304","volume":"21","author":"C Bozic","year":"2014","unstructured":"Bozic C, Subramanyam M, Richman S, Plavina T, Zhang A, Ticho B. Anti-JC virus (JCV) antibody prevalence in the JCV epidemiology in MS (JEMS) trial. Eur J Neurol. 2014;21:299\u2013304.","journal-title":"Eur J Neurol"},{"key":"578_CR18","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366:1870\u201380.","journal-title":"N Engl J Med"},{"key":"578_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1212\/WNL.0b013e3181f73600","volume":"75","author":"KL Amend","year":"2010","unstructured":"Amend KL, Turnbull B, Foskett N, Napalkov P, Kurth T, Seeger J. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology. 2010;75:1326\u201332.","journal-title":"Neurology"},{"key":"578_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.54.3.743","volume":"54","author":"C Power","year":"2000","unstructured":"Power C, Gladden JG, Halliday W, Del Bigio MR, Nath A, Ni W, et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology. 2000;54:743\u20136.","journal-title":"Neurology"},{"key":"578_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"FN Engsig","year":"2009","unstructured":"Engsig FN, Hansen A-BE, Omland LH, Kronborg G, Gerstoft J, Laursen AL, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2009;199:77\u201383.","journal-title":"J Infect Dis"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","volume":"155","author":"D Gobert","year":"2011","unstructured":"Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol. 2011;155:498\u2013508.","journal-title":"Br J Haematol"},{"key":"578_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaci.2011.05.024","volume":"128","author":"D Moshous","year":"2011","unstructured":"Moshous D, Meyts I, Fraitag S, Janssen CEI, Debr\u00e9 M, Suarez F, et al. Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-\u03b1 mAbs. J Allergy Clin Immunol. 2011;128:847\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"578_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","volume":"12","author":"JR Berger","year":"2017","unstructured":"Berger JR. Classifying PML risk with disease modifying therapies. Mult Scler Relat Disord. 2017;12:59\u201363.","journal-title":"Mult Scler Relat Disord"},{"key":"578_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/jnci\/djp256","volume":"101","author":"M Tuccori","year":"2009","unstructured":"Tuccori M, Focosi D, Blandizzi C, Del Tacca M, Petrini M. Re: rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst. 2009;101:1288\u20139 author reply 1289-1290.","journal-title":"J Natl Cancer Inst"},{"key":"578_CR26","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009;113:4834\u201340.","journal-title":"Blood"},{"key":"578_CR27","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.34468","volume":"64","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. 2012;64:3043\u201351.","journal-title":"Arthritis Rheum"},{"key":"578_CR28","first-page":"323","volume":"24","author":"JR Berger","year":"2018","unstructured":"Berger JR, Malik V, Lacey S, Brunetta P, Lehane PB. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event. J Neuro-Oncol. 2018;24:323\u201331.","journal-title":"J Neuro-Oncol"},{"key":"578_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ibd.20131","volume":"13","author":"A Lavagna","year":"2007","unstructured":"Lavagna A, Bergallo M, Daperno M, Sostegni R, Costa C, Leto R, et al. Infliximab and the risk of latent viruses reactivation in active Crohn\u2019s disease. Inflamm Bowel Dis. 2007;13:896\u2013902.","journal-title":"Inflamm Bowel Dis"},{"key":"578_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","volume":"47","author":"Y Jamilloux","year":"2017","unstructured":"Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, P\u00e9rard L, et al. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients. Semin Arthritis Rheum. 2017;47:288\u201394.","journal-title":"Semin Arthritis Rheum"},{"key":"578_CR31","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/pds.3320","volume":"21","author":"N Schmedt","year":"2012","unstructured":"Schmedt N, Andersohn F, Garbe E. Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf. 2012;21:1216\u201320.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"578_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/jnnp-2016-315106.113","volume":"87","author":"C McGuigan","year":"2016","unstructured":"McGuigan C, Craner M, Guadagno J, Kapoor R, Mazibrada G, Molyneux P, et al. Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. J Neurol Neurosurg Psychiatry. 2016;87:117\u201325.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"578_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11481-012-9366-z","volume":"7","author":"A Laroni","year":"2012","unstructured":"Laroni A, Giacomazzi CG, Grimaldi L, Gallo P, Sormani MP, Bertolotto A, et al. Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2012;7:665\u201372.","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"578_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/cir507","volume":"53","author":"RP Viscidi","year":"2011","unstructured":"Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, et al. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;53:711\u20135.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"578_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1468-1331.2011.03597.x","volume":"19","author":"MA Sahraian","year":"2012","unstructured":"Sahraian MA, Radue E-W, Eshaghi A, Besliu S, Minagar A. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol. 2012;19:1060\u20139.","journal-title":"Eur J Neurol"},{"key":"578_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jnnp-2014-308630","volume":"86","author":"MP Wattjes","year":"2015","unstructured":"Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Oosten BW, et al. MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry. 2015;86:793\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"578_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford DB, De Luca A, DeLuca A, Simpson DM, Arendt G, Giovannoni G, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010;9:438\u201346.","journal-title":"Lancet Neurol"},{"key":"578_CR38","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/bmt.2010.221","volume":"46","author":"A Balduzzi","year":"2011","unstructured":"Balduzzi A, Lucchini G, Hirsch HH, Basso S, Cioni M, Rovelli A, et al. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplant. 2011;46:987\u201392.","journal-title":"Bone Marrow Transplant"},{"key":"578_CR39","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1212\/01.wnl.0000183064.10227.b5","volume":"65","author":"L Kunschner","year":"2005","unstructured":"Kunschner L, Scott TF. Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2. Neurology. 2005;65:1510.","journal-title":"Neurology"},{"key":"578_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/jamaneurol.2014.825","volume":"71","author":"KB Alstadhaug","year":"2014","unstructured":"Alstadhaug KB, Croughs T, Henriksen S, Leboeuf C, Sereti I, Hirsch HH, et al. Treatment of progressive multifocal leukoencephalopathy with interleukin 7. JAMA Neurol. 2014;71:1030\u20135.","journal-title":"JAMA Neurol"},{"key":"578_CR41","doi-asserted-by":"publisher","first-page":"ofu074","DOI":"10.1093\/ofid\/ofu074","volume":"1","author":"J Gasnault","year":"2014","unstructured":"Gasnault J, de Go\u00ebr de Herve M-G, Michot J-M, Hendel-Chavez H, Seta V, Mazet A-A, et al. Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy. Open Forum Infect Dis. 2014;1:ofu074.","journal-title":"Open Forum Infect Dis"},{"key":"578_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","volume":"8","author":"D Pavlovic","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord. 2015;8:255\u201373.","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0578-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0578-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:17:40Z","timestamp":1576282660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0578-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0578-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective data collection was conducted according to the Helsinki Declaration and informed consent was obtained from the patients or their relatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}